Recent developments in nuclear magnetic resonance (NMR) technology have led to a new and extremely promising diagnostic technique, proton NMR tomography. Using a suitable radiofrequency pulse sequence (saturation-recovery, inversionrecovery, or spin-echo), it is possible to obtain images of high quality that often aid in the characterization of pathologic processes, especially within the brain [1 -10] . Differentiation of tissue from normal is provided when a distinction exists between the spin-lattice and/or spin-spin relaxation times of a lesion and those of surrounding normal tissues.
Other factors that influence signal intensity, such as hydrogenproton concentration and proton motion, seem to play a lesser role than relaxation times in most cases.
If were used as reference solutions.
Proton Relaxation Effects
The effects of the paramagnetic compounds on proton relaxation a pulse NMR spectrometer (Minispec pc 20, Bruker, Karisruhe, W. Germany) for inversion-recovery and Carr-Purcell-Meiboom-Gill pulse sequences.
Tolerance
The acute intravenous tolerance (LD ) of test solutions was evaluated by administration of different volumes of each agent directly into the tail veins of rats. Outbred male and female rats (strain: WistarHan-Schering) weighing 90-1 1 0 g were given a single intravenous injection at one of two to four dose levels; three to six animals were given each dose. The injection rate was 2 mI/mm and the rats were observed for 7 days after the injection. The concentration of test solution was 0.5 mol/L Gd-DTPA, 0.1 mol/L GdCI3 and Gd-EDTA, or 306 mg I/mI for diatrizoate. The amount ofcompound producing 50% mortality (LDse) was determined by interpolation from the results of different dose levels. A 0.5 mol/L solution of Na.Ca-DTPA (Heyl, W. Germany), a chelating drug used to treat heavy-metal poisoning, was also tested for LOse as a comparison.
Neural tolerance was assessed by intracisternal injection in male and female rats. The amounts of each compound producing SO% morbidity (EDse) (lack of motor coordination or epileptoid fit) and 50% mortality (LDse) were determined by interpolation from the results of four to 1 0 dose levels, each administered to 10 animals [27] . Because the in-vivo tolerance of contrast media correlates with the hydrophylicity, the partition coefficients of Gd-DTPA and diatnzoate were determined in a n-butanol-buffer mixture at pH 7.6 [28].
In order to establish whether Gd-DTPA causes some of the side effects known from radiographic contrast media the potential influence of Gd-DTPA and diatrizoate on the complement system was measured using the method of activation described by MUtzel et al. [29] . used for the study of excretion and organ distribution, was 2 MBq/mmol; for blood-and plasma-level studies, an activity of 0.15 MBq/mmol was used. Free gadolinium was not detectable (below 0.01 %) by means of thin-layer chromatography or xylenol orange as indicator [26] . The Gd activity was measured with the aid of a gamma scintillation counter (Compu Gamma 1282, LKB/Wallac, Finland).
Pharmacokinetics
Renal and fecal excretions were analyzed for 7 days after intravenous administration of 0.5 mmol/kg radiolabeled Gd-DTPA or 0.25 mmol/kg radiolabeled GdCl3 in five male rats (1 40-1 60 g ). In another experiment using five rats, serial blood, urine, and plasma concentrations of Gd-DTPA were determined for 3 hr after intravenous injection of 0.5 mmol/kg. For each time point, blood was taken from three to five animals. Half-lives of Gd-DTPA disappearance were then calculated for blood, plasma, and urine from levels of radiolabel; values were based on computer calculation using an open one-compartment model [30] . Gadolinium concentrations in kidney, liver, and spleen and the amount of gadolinium remaining in the organism were determined 7 days after injection.
Results

Proton
Relaxation Effects of Gadolinium Compounds
The free gadolinium ion (Gd3 ) and the two gadolinium chelates produced distinct effects on the Ti and T2 relaxation times of hydrogen protons in aqueous solutions ( 
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. LD50 in male and female rats (90-i i 0 g) after intravenous injection (2m1/min) lethal toxicity. The overall best neural tolerance was observed for gadolinium chelated with DTPA; for Gd-DTPA, the values of the LDso were 1 0 times higher than ED values with both routes of neural administration.
Both Gd-DTPA and diatrizoate are very hydrophilic substances.
Partition coefficients (log P) of -2.7 and -1 .3 were measured for the gadolinium chelate and the iodinated contrast agent, respectively.
However, the butanol-buffer partition coefficient of Gd-DTPA is about 25 times smaller than that of the iodinated compound.
The in-vitro investigation of complement activation showed that 50% of plasma complement remained at a diatrizoate concentration of 04 mol/L. In the case of Gd-DTPA, practically no influence on the complement system was detected; 50% activation required 2.5 mol/L.
Pharmacokinetics
At 5 mm after intravenous injection of 0.5 mmol/kg Gd-DTPA into the rats, about 1 0% of the dose could be detected in the whole blood volume.
The blood concentration subsequently decreased with a half-life of about 20 mm ( fig. 2) blood cells; the concentration in plasma remained i .6 times higher than in blood over 2 hr of observation.
A half-life of about 20 mm was observed for renal excretion up to 3 hr after injection.
By 3 hr, more than 80% of the compound had been excreted from the organism in urine (table 4) . By 7 days after intravenous injection, a total of 90% of the dose had been recovered in the urine and another 7%
Note-Data from inlection of 0.5 mmol/kg Gd-DTPA in five male rats weighing 140-160g.
. Time given in days unless indicated otherwise.
was recovered in the feces. Less than O.3% of the given dose was found in the organism, with 0.08% of the dose being detected in the liver and 0.i % in the kidneys. By 7 days after intravenous injection of radiolabeled GdCl3, only 2% of the dose had been excreted.
The major portion was discovered in the liver and spleen, about 60% being in the liver and 25% in the spleen (table 5). 
